Chi-Liang Eric. Yen, et.al., Deficiency of the intestinal enzyme acyl CoA:monoacylglycerol acyltransferase-2 protects mice from metabolic disorders induced by high-fat feeding., Nature medicine, 2009, 15

http://rdf.ncbi.nlm.nih.gov/pubmed/19287392

Chi-Liang Eric. Yen, et.al., Deficiency of the intestinal enzyme acyl CoA:monoacylglycerol acyltransferase-2 protects mice from metabolic disorders induced by high-fat feeding., Nature medicine, 2009, 15

http://rdf.ncbi.nlm.nih.gov/pubmed/

トランスクリプトームデータ

http://rdf.ncbi.nlm.nih.gov/pubmed/

• CD43885
  http://metadb.riken.jp/db/BrainTx/TranscriptomeData/CD43885

allele

http://purl.org/net/cito/citesAsAuthority

• Mogat2<tm1Far>
  http://metadb.riken.jp/db/mgi_rdf/MGI:3848538

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• decreased circulating insulin level_Mogat2<tm1Far>/Mogat2<tm1Far>
  http://metadb.riken.jp/0002727B6129S4Mogat2tm1FarMogat2tm1FarMogat2tm1FarMogat2tm1Far
• decreased circulating cholesterol level_Mogat2<tm1Far>/Mogat2<tm1Far>
  http://metadb.riken.jp/0005179B6129S4Mogat2tm1FarMogat2tm1FarMogat2tm1FarMogat2tm1Far
• decreased circulating triglyceride level_Mogat2<tm1Far>/Mogat2<tm1Far>
  http://metadb.riken.jp/0002644B6129S4Mogat2tm1FarMogat2tm1FarMogat2tm1FarMogat2tm1Far
• abnormal intestinal lipid absorption_Mogat2<tm1Far>/Mogat2<tm1Far>
  http://metadb.riken.jp/0005342B6129S4Mogat2tm1FarMogat2tm1FarMogat2tm1FarMogat2tm1Far
• increased body temperature_Mogat2<tm1Far>/Mogat2<tm1Far>
  http://metadb.riken.jp/0005533B6129S4Mogat2tm1FarMogat2tm1FarMogat2tm1FarMogat2tm1Far
• improved glucose tolerance_Mogat2<tm1Far>/Mogat2<tm1Far>
  http://metadb.riken.jp/0005292B6129S4Mogat2tm1FarMogat2tm1FarMogat2tm1FarMogat2tm1Far
• decreased susceptibility to diet-induced obesity_Mogat2<tm1Far>/Mogat2<+>
  http://metadb.riken.jp/0005659B6129S4Mogat2tm1FarMogat2tm1FarMogat2Mogat2tm1FarMogat2
• decreased susceptibility to hepatic steatosis_Mogat2<tm1Far>/Mogat2<tm1Far>
  http://metadb.riken.jp/0002310B6129S4Mogat2tm1FarMogat2tm1FarMogat2tm1FarMogat2tm1Far
• decreased circulating LDL cholesterol level_Mogat2<tm1Far>/Mogat2<tm1Far>
  http://metadb.riken.jp/0000183B6129S4Mogat2tm1FarMogat2tm1FarMogat2tm1FarMogat2tm1Far
• decreased brown fat cell number_Mogat2<tm1Far>/Mogat2<tm1Far>
  http://metadb.riken.jp/0009128B6129S4Mogat2tm1FarMogat2tm1FarMogat2tm1FarMogat2tm1Far
• increased oxygen consumption_Mogat2<tm1Far>/Mogat2<tm1Far>
  http://metadb.riken.jp/0005289B6129S4Mogat2tm1FarMogat2tm1FarMogat2tm1FarMogat2tm1Far
• decreased percent body fat/body weight_Mogat2<tm1Far>/Mogat2<tm1Far>
  http://metadb.riken.jp/0005459B6129S4Mogat2tm1FarMogat2tm1FarMogat2tm1FarMogat2tm1Far
• decreased circulating VLDL cholesterol level_Mogat2<tm1Far>/Mogat2<tm1Far>
  http://metadb.riken.jp/0005146B6129S4Mogat2tm1FarMogat2tm1FarMogat2tm1FarMogat2tm1Far
• decreased susceptibility to hyperlipidemia_Mogat2<tm1Far>/Mogat2<tm1Far>
  http://metadb.riken.jp/0002323B6129S4Mogat2tm1FarMogat2tm1FarMogat2tm1FarMogat2tm1Far
• decreased susceptibility to diet-induced obesity_Mogat2<tm1Far>/Mogat2<tm1Far>
  http://metadb.riken.jp/0005659B6129S4Mogat2tm1FarMogat2tm1FarMogat2tm1FarMogat2tm1Far